Calumet, Inc. (NASDAQ:CLMT) Short Interest Up 21.1% in February

Calumet, Inc. (NASDAQ:CLMT) was the recipient of a large growth in short interest during the month of February. As of February 13th, there was short interest totaling 6,970,191 shares, a growth of 21.1% from the January 29th total of 5,755,371 shares. Based on an average daily trading volume, of 1,580,686 shares, the short-interest ratio is presently 4.4 days. Approximately 8.4% of the shares of the company are short sold. Approximately 8.4% of the shares of the company are short sold. Based on an average daily trading volume, of 1,580,686 shares, the short-interest ratio is presently 4.4 days.

Calumet Stock Performance

Calumet stock opened at $30.29 on Friday. Calumet has a fifty-two week low of $7.68 and a fifty-two week high of $30.52. The stock has a market cap of $2.63 billion, a P/E ratio of -77.66 and a beta of 1.18. The firm’s fifty day moving average price is $23.77 and its 200-day moving average price is $20.32.

Calumet (NASDAQ:CLMT) last issued its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.24. The business had revenue of ($3,098.50) million for the quarter, compared to analysts’ expectations of $1.04 billion. The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.47) EPS. Sell-side analysts predict that Calumet will post -3.02 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on CLMT shares. Wall Street Zen downgraded shares of Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. HC Wainwright reiterated a “buy” rating and issued a $33.00 price objective on shares of Calumet in a research note on Monday, November 10th. Weiss Ratings reissued a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. The Goldman Sachs Group raised their price target on Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a report on Friday, January 30th. Finally, TD Cowen lifted their price target on Calumet from $19.00 to $25.00 and gave the company a “hold” rating in a research report on Thursday. Four investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $24.00.

Trending Headlines about Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright keeps a “Buy” rating and a $33 price target on CLMT, a level above the current price that supports upside expectations for investors. The firm continues to publish multi-year recovery forecasts despite near-term losses. HC Wainwright Research Coverage
• Neutral Sentiment: Reported short-interest data shows 0 shares short and a 0.0 days-to-cover metric — likely a reporting anomaly. If accurate, negligible short interest removes a potential downside pressure, but the entry appears unreliable and should be viewed cautiously.
• Neutral Sentiment: A FY2029 earnings forecast was published by HC Wainwright (reported on AmericanBankingNews), but the item provides a forward-looking projection without new operational details; useful for modeling but not an immediate catalyst. FY2029 Forecast
• Neutral Sentiment: A PR Newswire release highlights record sales for TRUFUEL®. If TRUFUEL is part of Calumet’s branded products mix, rising consumer/retail sales support longer-term revenue diversification; however, the release is a general industry/brand sales item rather than direct corporate financial guidance. TRUFUEL Record Sales
• Negative Sentiment: TD Cowen raised its price target from $19 to $25 but maintained a “Hold” rating — their $25 target implies downside relative to the current trade level, signaling limited near-term upside from this shop and offering a mixed signal despite the higher target. TD Cowen Target Update
• Negative Sentiment: HC Wainwright materially lowered near- and medium-term EPS forecasts (FY2026, FY2027 and FY2028 revisions downward), trimming FY2026 to a larger loss and reducing FY2028 upside. Those cuts are a direct negative to valuation and short-term expectations despite the maintained Buy rating and $33 target. HC Wainwright EPS Revisions

Hedge Funds Weigh In On Calumet

A number of hedge funds and other institutional investors have recently modified their holdings of CLMT. Two Seas Capital LP boosted its stake in Calumet by 56.9% in the second quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock worth $70,860,000 after buying an additional 1,631,098 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Calumet by 112.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,704,670 shares of the oil and gas company’s stock worth $26,860,000 after acquiring an additional 901,933 shares during the last quarter. AYAL Capital Advisors Ltd purchased a new stake in shares of Calumet in the 2nd quarter valued at $5,278,000. Mariner LLC boosted its stake in shares of Calumet by 959.6% in the 3rd quarter. Mariner LLC now owns 369,408 shares of the oil and gas company’s stock valued at $6,742,000 after purchasing an additional 334,544 shares in the last quarter. Finally, Marshall Wace LLP grew its holdings in shares of Calumet by 35.8% during the 3rd quarter. Marshall Wace LLP now owns 891,390 shares of the oil and gas company’s stock valued at $16,268,000 after purchasing an additional 234,766 shares during the last quarter. 34.41% of the stock is currently owned by hedge funds and other institutional investors.

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.